Last reviewed · How we verify
Lapyrium (LAPYRIUM CHLORIDE)
At a glance
| Generic name | LAPYRIUM CHLORIDE |
|---|---|
| Sponsor | Chesebrough Ponds |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lapyrium CI brief — competitive landscape report
- Lapyrium updates RSS · CI watch RSS
- Chesebrough Ponds portfolio CI